Table 3

Association of type of TB, sputum smear conversion, HIV/TB coinfection and treatment outcome with type of DOTS approaches among the study participants

VariablesTotal cohort
(N=1161)
Patients under FB-DOTS (n=774)
n (%)
Patients under CB-DOTS (n=387)
n (%)
P value
TB classificationSmear-positive PTB567364 (47.0)203 (52.5)0.097
Smear-negative PTB251166 (21.5)85 (22.0)
Extrapulmonary TB343244 (31.5)99 (25.5)
TB treatment categoryNew1123747 (96.5)376 (97.2)0.560
Retreatment3827 (3.5)11 (2.8)
HIV statusReactive3831 (4.0)7 (1.8)<0.001
Non-reactive1040669 (86.4)371 (95.9)
Unknown8374 (9.6)9 (2.3)
Contact person registered with addressYes1104722 (93.3)382 (98.7)<0.001
No5752 (6.7)5 (1.3)
Sputum result at the end of second or third monthNegative493318 (41.1)175 (45.2)0.216*
Positive1611 (1.4)5 (1.3)
Not done5834 (4.4)24 (6.2)
Not applicable594411 (53.1)183 (47.3)
Sputum result at the end fifth monthNegative434280 (36.2)154 (39.8)0.150*
Positive53 (0.4)2 (0.6)
Not done12073 (9.4)47 (12.1)
Not applicable602418 (54.0)184 (47.5)
Sputum result at the end the treatmentNegative399260 (33.6)139 (35.9)0.042*
Positive33 (0.4)0 (0.00)
Not done15692 (11.9)64 (16.5)
Not applicable603419 (54.1)184 (47.6)
TB treatment outcomesCured435279 (36.1)156 (40.3)0.756*
Treatment completed573390 (50.4)183 (47.3)
Died4128 (3.6)13 (3.4)
Treatment failure107 (0.8)3 (0.7)
Lost to follow-up1510 (1.3)5 (1.3)
Transferred out3426 (3.4)8 (2.1)
Not recorded5334 (4.4)19 (4.9)
TB treatment outcome categoryFavourable outcome1008669 (86.4)339 (87.6)0.854
Unfavourable outcome6645 (5.8)21 (5.4)
Unknown outcome8760 (7.8)27 (7.0)
  • *Fisher’s exact test was applied.

  • CB-DOTS, community-based directly observed treatment, short course ; FB-DOTS, facility-based directly observed treatment, short course ; TB, tuberculosis.